Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-24 @ 12:10 AM
Study NCT ID:
NCT07194005
Status:
RECRUITING
Last Update Posted:
2025-09-26
First Post:
2025-09-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
Sponsor:
Organization: